| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786161 | Clinical Oncology | 2018 | 10 Pages |
Abstract
Hyperglycaemia is associated with adverse overall survival and DFS in patients with cancer. The therapeutic role of glycaemic control in cancer patients warrants further investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
R. Barua, A.J. Templeton, B. Seruga, A. Ocana, E. Amir, J.-L. Ethier,